Arineta’s SpotLight Duo Enhances Cardiovascular Care in Mississippi

Prime Heart and Vascular Care in Corinth establishes Mississippi as a leader in state-of-the-art cardiac imaging

Caesarea, Israel – April 23, 2024Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, announces the installation of SpotLight™ Duo at Prime Heart and Vascular Care in Corinth, Mississippi. This is a significant advancement in improving cardiac care in a region where healthcare access, particularly for cardiovascular care, faces unique challenges.


Mississippi residents have the lowest life expectancy amongst all states at just 72 years old, 5 fewer than the national average. Additionally the state has the second highest rate of heart disease deaths in the nation and in the top 5 for most obese states. With this installation, patients in Corinth and surrounding areas are able to gain access to cutting-edge technology previously only available in metropolitan areas.


Prime Heart and Vascular Care, led by cardiologist Mandar R. Jagtap, MD, currently serves over 8,000 patients and, with the addition of the FDA-cleared SpotLight Duo, they will have access to the most advanced thoracic and cardiac imaging. With its compact design, the non-invasive system provides point-of-care access to diagnostics, therapy planning, and monitoring.


“The addition of Arineta’s SpotLight Duo to our facility represents a significant advancement in our ability to provide top-quality cardiovascular care to our community,” said Dr. Jagtap. “This revolutionary technology will transform the standard of care in cardiovascular diagnosis and treatment in an area where access to such advanced equipment has been limited.”


The single beat, whole heart scanner is optimized with 140 mm coverage at a rotation speed of 0.24 sec per rotation. Its deep-learning imaging reconstruction (DLIR) technology provides improved image quality by reconstructing cross-sectional images of the subject, allowing for a more complete image and more accurate diagnosis. Enabled by Arineta’s proprietary Stereo CT technology, it offers best-in-class specifications for temporal resolution of 120 msec with 45cm high resolution scanning.


“With the arrival of SpotLight Duo at Prime Heart and Vascular Care, we are advancing our mission to provide  access to state of the art cardiovascular imaging”, said CEO Doug Ryan. “In a region grappling with significant health disparities, this installation is a step towards addressing the challenge head-on.”


About Arineta

Arineta is an Israeli company that develops and produces innovative cardiovascular imaging solutions. It is dedicated to growing cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease, the no. 1 cause of death and costs for healthcare worldwide. Arineta’s flagship product, SpotLight™ Duo, is the world’s first dedicated single-heartbeat, whole-heart cardiovascular and thoracic CT, based on the company’s proprietary Stereo CT technology. The company is part of a long tradition of medical imaging innovation that began in Israel in the 1970s. Among Arineta’s scientists are the inventors of the multi-slice spiral CT technology, still the cornerstone of CT imaging, and several other key technologies.


For more information, visit

Read all the related Press clippings here: